10X Genomics Inc (TXG)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $7.23B
Last updated: Nov 17, 2026 at 4:43 PM ET
10X Genomics Inc (TXG) Stock Chart
10X Genomics (TXG) has a latest price of $56.30 on Nov 17, 2026, 45.2% below its 52-week high of $102.81. Its price rose 254.3% over the past 12 months. The month-end price fell 56.5% over the 5 years through Oct 2026, a compound annual decline of 15.3%.
Price Chart
From Sep 2019 to Oct 2026, its highest month-end close was $197.80 in Apr 2021 and its lowest $8.27 in Apr 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TXG with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TXG.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 9.5%, and over 6 months it rose 152.6%. The month-end price rose 98.7% over the 3 years through Oct 2026, a compound annual rate of 25.7%.
| Period | Change |
|---|---|
| 1 month | -19.4% |
| 3 months | -9.5% |
| 6 months | +152.6% |
| 12 months | +254.3% |
| 12 months, with dividends | +254.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +98.7% | +25.7% |
| 5 years | -56.5% | -15.3% |
Price by Year
Its best calendar year was 2020, when the price rose 85.7%, and its weakest was 2022, when it fell 75.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $70.11 | +329.9% |
| 2025 | $16.31 | +13.6% |
| 2024 | $14.36 | -74.3% |
| 2023 | $55.96 | +53.6% |
| 2022 | $36.44 | -75.5% |
| 2021 | $148.96 | +5.2% |
| 2020 | $141.60 | +85.7% |
Trading Range
The price is 23.5% below its 50-day average of $73.58 and 31.1% above its 200-day average of $42.93.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $56.30 | |
| 52-week high | $102.81 | -45.2% |
| 52-week low | $15.18 | +270.9% |
| 50-day average | $73.58 | -23.5% |
| 200-day average | $42.93 | +31.1% |
Price Risk
Over 3 years, its largest fall from a peak was 87.6%.
| Measure | Value |
|---|---|
| 1-year beta | 2.48 |
| Largest fall, 1 year | -43.7% |
| Largest fall, 3 years | -87.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TXG
What is TXG's 1-year price change?
10X Genomics's price rose 254.3% over the past 12 months. With dividends included, the 12-month total return was 254.3%.
What is TXG's 5-year price change?
10X Genomics's month-end price fell 56.5% over the 5 years through Oct 2026, a compound annual decline of 15.3%. These figures leave out dividends.
What is TXG's 52-week high and low?
10X Genomics's 52-week high is $102.81 and its 52-week low is $15.18. Its latest price of $56.30 on Nov 17, 2026 is 45.2% below the high.
What is TXG's beta?
10X Genomics's 1-year beta against the S&P 500 is 2.48, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 43.7%.
Is the TXG chart free?
Yes. Advanced Charting for TXG is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TXG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts